A Phase 3 Study of Lu AA21004 in Patients With Major Depressive Disorder
NCT02389816
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
493
Enrollment
INDUSTRY
Sponsor class
Conditions
Major Depressive Disorder
Interventions
DRUG:
Placebo
DRUG:
Vortioxetine
Sponsor
Takeda